Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03271372
Title Adjuvant Avelumab in Merkel Cell Cancer (ADAM)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors University of Washington
Indications

Merkel cell carcinoma

Therapies

Avelumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.